Literature indicates that BA suppresses PD-L1 expression and modulates the AKT/mTOR signaling pathway, potentially mitigating tumor immune tolerance in vivo and offering a novel approach for anti-tumor immunotherapy (Liu et al., 2024). This evidence concerns the gene AKT1 and neoplasm.